This study will provide extended access to patients and assess longer-term outcomes on
patients who have completed the TUDCA-ALS study.
Phase:
Phase 3
Details
Lead Sponsor:
Humanitas Mirasole SpA
Collaborators:
Bruschettini S.r.l. Istituto Superiore di Sanità KU Leuven Motor Neurone Disease Association UMC Utrecht University Hospital, Tours University of Dublin, Trinity College University of Sheffield University of Ulm